Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.02.041Source: DataRank Database

Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis is a research paper published in Clinical Gastroenterology and Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.14)OA: bronzeTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Eric Trépo ORCID,Indu Raman ORCID,Quan‐Zhen Li ORCID,Delphine Degré,Thierry Gustot ORCID

Live enrichment

PubMed:33667676 PMC:PMC8410886 OpenAlex:https://openalex.org/W3134584407

European Commission

Grant: ERC-2014-AdG-671231

National Institutes of Health

Grant: DK099558

National Institutes of Health

Grant: CA233794

Cancer Prevention and Research Institute of Texas

Grant: RR180016

NCI NIH HHS

Grant: R01 CA233794

NIDDK NIH HHS

Grant: R01 DK099558

European Research Council

Grant: 671231

Cell circuits as targets and biomarkers for liver disease and cancer prevention

National Institutes of Health

Grant: 3R01CA233794-05S1

Reverse-engineering precision liver cancer chemoprevention

Uehara Memorial Foundation

FWCI

1.14

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2026

bronzeLicense: Elsevier TDM

journalhttp://www.cghjournal.org/article/S1542356521002202/pdf

BRONZEhttp://www.cghjournal.org/article/S1542356521002202/pdf

publisherhttp://www.cghjournal.org/article/S1542356521002202/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1542356521002202?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356521002202?httpAccept=text/plain

Fields of Study

Alcohol Consumption and Health EffectsLiver Disease Diagnosis and TreatmentAlcoholism and Thiamine DeficiencyMedicine0301 basic medicine0303 health sciences03 medical and health sciencesEnd Stage Liver DiseaseHepatitis, AlcoholicHumansLiver Function TestsPrognosisROC CurveRetrospective StudiesSeverity of Illness Index

MeSH Terms

Hepatitis, AlcoholicHumansLiver Function TestsPrognosisRetrospective StudiesROC CurveSeverity of Illness IndexEnd Stage Liver Disease

Keywords

MedicineLiver transplantationAlcoholic hepatitisInternal medicineGene signatureHazard ratioLiver diseaseFramingham Risk ScoreAlcoholic liver diseaseGastroenterologyCohortModel for End-Stage Liver DiseaseLiver biopsyProportional hazards modelTransplantationOncologyBiopsyDiseaseGene expressionGeneCirrhosisConfidence intervalBiologyBiomarkerDeathSevere Alcoholic HepatitisHepatitis, AlcoholicPrognosisSeverity of Illness IndexEnd Stage Liver DiseaseLiver Function TestsROC CurveGastro-entérologieHumansRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being